Predictable enriched environment prevents development of hyperemotionality in the VPA rat model of autism

Frontiers in Neuroscience

Volumn 9, Issue MAR, 2015, Pages

  Favre, Mônica Regina ^a   La Mendola, Deborah ^a   Meystre, Julie ^a   Christodoulou, Dimitri ^a   Cochrane, Melissa ^a   Markram, Henry ^a   Markram, Kamila ^a  

^a EPFL   (Switzerland)

Author keywords

Autism; Emotion; Environmental enrichment; Individual differences; Predictability; Protein expression; Rat; Valproic acid

Indexed keywords

CORTICOSTERONE; GLUTAMIC ACID; SODIUM CHLORIDE; VALPROIC ACID;

ADULTHOOD; AFFECT; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; AUTISM; BRAIN TISSUE; CLINICAL LABORATORY; CONTROLLED STUDY; CORRELATIONAL STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; EMBRYO; EMOTIONAL DISORDER; EMOTIONALITY; ENVIRONMENTAL ENRICHMENT; FEAR; HIPPOCAMPUS; HYPEREMOTIONALITY; MALE; NEUROCHEMISTRY; NEUROPROTECTION; NOCICEPTION; NONHUMAN; PREDICTION; PRIMARY SOMATOSENSORY CORTEX; PROTEIN EXPRESSION; PSYCHOSOCIAL WITHDRAWAL; RAT; REARING; RISK FACTOR; SENSORY DYSFUNCTION; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; STEREOTYPY;

EID: 84928114791     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00127     Document Type: Article

References (76)

1. Abrahams, B.S., and Geschwind, D.H. (2010). Connecting genes to brain in the autism spectrum disorders. Arch Neurol 67, 395-399. doi: 10.1001/archneurol.2010.47.
2. Almeida, L.E., Roby, C.D., and Krueger, B.K. (2014). Increased BDNF expression in fetal brain in the valproic acid model of autism. Mol Cell Neurosci 28, 57-62. doi: 10.1016/j.mcn.2014.01.007.
3. American Psychiatric Association (ed.). (2013). Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association.
4. Argyropoulos, A., Gilby, K.L., and Hill-Yardin, E.L. (2013). Studying autism in rodent models: reconciling endophenotypes with comorbidities. Front Hum Neurosci 7, 417. doi: 10.3389/fnhum.2013.00417.
5. Arndt, T.L., Stodgell, C.J., and Rodier, P.M. (2005). The teratology of autism. Int J Dev Neurosci 23, 189-199. doi: 10.1016/j.ijdevneu.2004.11.001.
6. Arnsten, A.F., and Rubia, K. (2012). Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry 51, 356-367. doi: 10.1016/j.jaac.2012.01.008.
7. Bent, S., and Hendren, R.L. (2010). Improving the prediction of response to therapy in autism. Neurotherapeutics 7, 232-240. doi: 10.1016/j.nurt.2010.05.011.
8. Betancur, C. (2011). Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380, 42-77. doi: 10.1016/j.brainres.2010.11.078.
9. Brentani, H., Paula, C.S., Bordini, D., Rolim, D., Sato, F., Portolese, J., Pacifico, M.C., and Mccracken, J.T. (2013). Autism spectrum disorders: an overview on diagnosis and treatment. Rev Bras Psiquiatr 35, 1516-4446. doi: 10.1590/1516-4446-2013-S104.
10. Buxbaum, J.D. (2009). Multiple rare variants in the etiology of autism spectrum disorders. Dialogues Clin Neurosci 11, 35-43. doi: n/a.
11. Chamberlain, P.D., Rodgers, J., Crowley, M.J., White, S.E., Freeston, M.H., and South, M. (2013). A potentiated startle study of uncertainty and contextual anxiety in adolescents diagnosed with autism spectrum disorder. Mol Autism 4, 31. doi: 10.1186/2040-2392-4-31.
12. Chapman, J.B., and Cutler, M.G. (1984). Sodium valproate: effects on social behaviour and physical development in the mouse. Psychopharmacology (Berl) 83, 390-396. doi: 10.1007/BF00428553.
13. Chomiak, T., and Hu, B. (2013). Alterations of neocortical development and maturation in autism: Insight from valproic acid exposure and animal models of autism. Neurotoxicol Teratol 36, 57-66. doi: 10.1016/j.ntt.2012.08.005.
14. Choudhury, P.R., Lahiri, S., and Rajamma, U. (2012). Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacol Biochem Behav 100, 841-849. doi: 10.1016/j.pbb.2011.06.023.
15. Christensen, J., Gronborg, T.K., Sorensen, M.J., Schendel, D., Parner, E.T., Pedersen, L.H., and Vestergaard, M. (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309, 1696-1703. doi: 10.1001/jama.2013.2270.
16. Clayton-Smith, J., and Donnai, D. (1995). Fetal valproate syndrome. J Med Genet 32, 724-727. doi: 10.1136/jmg.32.9.724.
17. Contestabile, A., and Sintoni, S. (2013). Histone acetylation in neurodevelopment. Curr Pharm Des 19, 5043-5050. doi: 10.2174/1381612811319280003.
18. Cotariu, D., Zaidman, J.L., and Evans, S. (1990). Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system. Prog Neurobiol 34, 343-354. doi: 10.1016/0301-0082(90)90010-E.
19. Courchesne, E., Campbell, K., and Solso, S. (2011). Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res 1380, 138-145. doi: 10.1016/j.brainres.2010.09.101.
20. De Kloet, E.R., Fitzsimons, C.P., Datson, N.A., Meijer, O.C., and Vreugdenhil, E. (2009). Glucocorticoid signaling and stress-related limbic susceptibility pathway: about receptors, transcription machinery and microRNA. Brain Res 1293, 129-141. doi: 10.1016/j.brainres.2009.03.039.
21. Edalatmanesh, M.A., Nikfarjam, H., Vafaee, F., and Moghadas, M. (2013). Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism. Brain Res 14, 15-25. doi: 10.1016/j.brainres.2013.06.024.
22. El-Kordi, A., Winkler, D., Hammerschmidt, K., Kastner, A., Krueger, D., Ronnenberg, A., Ritter, C., Jatho, J., Radyushkin, K., Bourgeron, T., Fischer, J., Brose, N., and Ehrenreich, H. (2013). Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behav Brain Res 251, 41-49. doi: 10.1016/j.bbr.2012.11.016.
23. Ellis, B.J., and Boyce, W.T. (2011). Differential susceptibility to the environment: toward an understanding of sensitivity to developmental experiences and context. Dev Psychopathol 23, 1-5. doi: 10.1017/S095457941000060X.
24. Favre, M.R., Barkat, T.R., Lamendola, D., Khazen, G., Markram, H., and Markram, K. (2013). General developmental health in the VPA-rat model of autism. Front Behav Neurosci 7, 88. doi: 10.3389/fnbeh.2013.00088.
25. Fernando, A.B., Murray, J.E., and Milton, A.L. (2013). The amygdala: securing pleasure and avoiding pain. Front Behav Neurosci 7, 00190. doi: 10.3389/fnbeh.2013.00190.
26. Ferrara, C., and Hill, S.D. (1980). The responsiveness of autistic children to the predictability of social and nonsocial toys. J Autism Dev Disord 10, 51-57. doi: 10.1007/BF02408432.
27. Flannery, K.B., Horner, R. H. (1994). The relationship between predictability and problem behavior for students with severe disabilities. Journal of Behavioral Education 4, 157-176. doi: 10.1007/BF01544110.
28. Fossati, P. (2012). Neural correlates of emotion processing: from emotional to social brain. Eur Neuropsychopharmacol 22, S487-491. doi: 10.1016/j.euroneuro.2012.07.008.
29. Gaigg, S.B. (2012). The interplay between emotion and cognition in Autism Spectrum Disorder: Implications for developmental theory. Frontiers in Integrative Neuroscience 6, 113. doi: 10.3389/fnint.2012.00113.
30. Gomot, M., and Wicker, B. (2012). A challenging, unpredictable world for people with autism spectrum disorder. Int J Psychophysiol 83, 240-247. doi: 10.1016/j.ijpsycho.2011.09.017.
31. Gottfried, C., Bambini-Junior, V., Baronio, D., Zanatta, G., Bristot Silvestrin, R., Vaccaro, T., and Riesgo, R. (2013). Valproic Acid in Autism Spectrum Disorder: From an Environmental Risk Factor to a Reliable Animal Model, Recent Advances in Autism Spectrum Disorders-Volume I. Intech.
32. Graff, J., and Tsai, L.H. (2013). Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci 14, 97- 111. doi: 10.1038/nrn3427.
33. Gresham, F.M., Beebe-Frankenberger, Margaret E., Macmillan, Donald L. (1999). A selective review of treatments for children with autism: Description and methodological considerations. School Psychology Review 28, 559-575. doi: n/a.
34. Groeneweg, F.L., Karst, H., De Kloet, E.R., and Joels, M. (2011). Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 209, 153-167. doi: 10.1530/JOE-10-0472.
35. Hannan, A.J. (2014). Review: Environmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity. Neuropathology and Applied Neurobiology 40, 13-25. doi: 10.1111/nan.12102.
36. Kim, K.C., Kim, P., Go, H.S., Choi, C.S., Park, J.H., Kim, H.J., Jeon, S.J., Dela Pena, I.C., Han, S.H., Cheong, J.H., Ryu, J.H., and Shin, C.Y. (2013). Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder. J Neurochem 124, 832-843. doi: 10.1111/jnc.12147.
37. Kim, K.C., Lee, D.K., Go, H.S., Kim, P., Choi, C.S., Kim, J.W., Jeon, S.J., Song, M.R., and Shin, C.Y. (2014). Pax6- dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring. Mol Neurobiol 49, 512-528. doi: 10.1007/s12035-013-8535-2.
38. Kini, U. (2006). Fetal valproate syndrome: a review. Paediatric and Perinatal Drug Therapy 7, 123-130. doi: 10.1185/146300906x112908.
39. Kootz, J.P., Marinelli, B., and Cohen, D.J. (1982). Modulation of response to environmental stimulation in autistic children. J Autism Dev Disord 12, 185-193. doi: 10.1007/BF01531308.
40. Lai, M.C., Lombardo, M.V., and Baron-Cohen, S. (2014). Autism. Lancet 383, 896-910. doi: 10.1016/S0140- 6736(13)61539-1.
41. Leblanc, L.A., and Gillis, J.M. (2012). Behavioral interventions for children with autism spectrum disorders. Pediatr Clin North Am 59, 147-164, xi-xii. doi: 10.1016/j.pcl.2011.10.006.
42. Markram, H., Rinaldi, T., and Markram, K. (2007). The intense world syndrome-an alternative hypothesis for autism. Front Neurosci 1, 77-96. doi: 10.3389/neuro.01.1.1.006.2007.
43. Markram, K., and Markram, H. (2010). The intense world theory-a unifying theory of the neurobiology of autism. Front Hum Neurosci 4, 224. doi: 10.3389/fnhum.2010.00224.
44. Markram, K., Rinaldi, T., La Mendola, D., Sandi, C., and Markram, H. (2008). Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 33, 901-912. doi: 10.1038/sj.npp.1301453.
45. Martin, H.G., and Manzoni, O.J. (2014). Late onset deficits in synaptic plasticity in the valproic acid rat model of autism. Front Cell Neurosci 8. doi: 10.3389/fncel.2014.00023.
46. Moldin, S.O., and Rubenstein, J.L.R. (eds.). (2006). Understanding Autism: From Basic Neuroscience to Treatment. CRC Press.
47. Mottron, L. (2011). Changing perceptions: The power of autism. Nature 479, 33-35. doi: 10.1038/479033a.
48. Oguchi-Katayama, A., Monma, A., Sekino, Y., Moriguchi, T., and Sato, K. (2013). Comparative gene expression analysis of the amygdala in autistic rat models produced by pre- and post-natal exposures to valproic acid. J Toxicol Sci 38, 391-402. doi: DN/JST.JSTAGE/jts/38.391 [pii].
49. Pang, T.Y., and Hannan, A.J. (2013). Enhancement of cognitive function in models of brain disease through environmental enrichment and physical activity. Neuropharmacology 64, 515-528. doi: 10.1016/j.neuropharm.2012.06.029.
50. Parellada, M., Penzol, M.J., Pina, L., Moreno, C., González-Vioque, E., Zalsman, G., and Arango, C. (2014). The neurobiology of autism spectrum disorders. European Psychiatry 29, 11-19. doi: http://dx.doi.org/10.1016/j.eurpsy.2013.02.005.
51. Paxinos, G., and Watson, C. (1998). The rat brain in stereotaxic coordinates. San Diego: Academic Press.
52. Rinaldi, T., Kulangara, K., Antoniello, K., and Markram, H. (2007). Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proceedings of the National Academy of Sciences 104, 13501-13506. doi: 10.1073/pnas.0704391104.
53. Rinaldi, T., Perrodin, C., and Markram, H. (2008a). Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic Acid animal model of autism. Front Neural Circuits 2, 4. doi: 10.3389/neuro.04.004.2008.
54. Rinaldi, T., Silberberg, G., and Markram, H. (2008b). Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex 18, 763-770. doi: 10.1093/cercor/bhm117.
55. Rodier, P.M., Ingram, J.L., Tisdale, B., and Croog, V.J. (1997). Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol 11, 417-422. doi: 10.1016/S0890-6238(97)80001-U.
56. Rodier, P.M., Ingram, J.L., Tisdale, B., Nelson, S., and Romano, J. (1996). Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 370, 247-261. doi: 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2.
57. Rossignol, D.A. (2009). Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry 21, 213-236. doi: n/a.
58. Roullet, F.I., and Crawley, J.N. (2011). Mouse models of autism: testing hypotheses about molecular mechanisms. Curr Top Behav Neurosci 7, 187-212. doi: 10.1007/7854_2010_113.
59. Roullet, F.I., Lai, J.K., and Foster, J.A. (2013). In utero exposure to valproic acid and autism--a current review of clinical and animal studies. Neurotoxicol Teratol 36, 47-56. doi: 10.1016/j.ntt.2013.01.004.
60. Rout, U.K., and Clausen, P. (2009). Common increase of GATA-3 level in PC-12 cells by three teratogens causing autism spectrum disorders. Neurosci Res 64, 162-169. doi: 10.1016/j.neures.2009.02.009.
61. Sandi, C. (2011). Glucocorticoids act on glutamatergic pathways to affect memory processes. Trends Neurosci 34, 165- 176. doi: 10.1016/j.tins.2011.01.006.
62. Schneider, T., Turczak, J., and Przewlocki, R. (2006). Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 31, 36-46. doi: 10.1038/sj.npp.1300767.
63. Silva, G.T., Le Be, J.V., Riachi, I., Rinaldi, T., Markram, K., and Markram, H. (2009). Enhanced long-term microcircuit plasticity in the valproic Acid animal model of autism. Front Synaptic Neurosci 1, 1. doi: 10.3389/neuro.19.001.2009.
64. Sinha, P., Kjelgaard, M.M., Gandhi, T.K., Tsourides, K., Cardinaux, A.L., Pantazis, D., Diamond, S.P., and Held, R.M. (2014). Autism as a disorder of prediction. Proceedings of the National Academy of Sciences 111, 15220- 15225. doi: 10.1073/pnas.1416797111.
65. Smith, A.L., and Corrow, D.J. (2005). Modifications to husbandry and housing conditions of laboratory rodents for improved well-being. ILAR J 46, 140-147. doi: 10.1093/ilar.46.2.140.
66. Sterling-Turner, H.E., Jordan, Sara S. (2007). Interventions addressing transition difficulties for individuals with autism. Psychology in the Schools 44, 681-690. doi: 10.1002/pits.20257.
67. Sui, L., and Chen, M. (2012). Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories. Brain Res Bull 87, 556-563. doi: 10.1016/j.brainresbull.2012.01.011.
68. Sweatt, J.D. (2009). Experience-dependent epigenetic modifications in the central nervous system. Biol Psychiatry 65, 191-197. doi: 10.1016/j.biopsych.2008.09.002.
69. Van Praag, H., Kempermann, G., and Gage, F.H. (2000). Neural consequences of environmental enrichment. Nat Rev Neurosci 1, 191-198. doi: 10.1038/35044558.
70. Vivanti, G., Prior, M., Williams, K., and Dissanayake, C. (2014). Predictors of outcomes in Autism Intervention: Why don't we know more? Frontiers in Pediatrics 2, 58. doi: 10.3389/fped.2014.00058.
71. Wagner, G.C., Reuhl, K.R., Cheh, M., Mcrae, P., and Halladay, A.K. (2006). A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J Autism Dev Disord 36, 779-793. doi: 10.1007/s10803-006-0117-y.
72. Walcott, E.C., Higgins, E.A., and Desai, N.S. (2011). Synaptic and intrinsic balancing during postnatal development in rat pups exposed to valproic acid in utero. J Neurosci 31, 13097-13109. doi: 10.1523/JNEUROSCI.1341- 11.2011
73. White, S.W., Oswald, D., Ollendick, T., and Scahill, L. (2009). Anxiety in children and adolescents with autism spectrum disorders. Clin Psychol Rev 29, 216-229. doi: 10.1016/j.cpr.2009.01.003.
74. Woo, C.C., and Leon, M. (2013). Environmental enrichment as an effective treatment for autism: A randomized controlled trial. Behav Neurosci 127, 487-497. doi: 10.1037/a0033010.
75. Zahir, F.R., and Brown, C.J. (2011). Epigenetic impacts on neurodevelopment: pathophysiological mechanisms and genetic modes of action. Pediatr Res 69, 92R-100R. doi: 10.1203/PDR.0b013e318213565e.
76. Zikopoulos, B., and Barbas, H. (2013). Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front Hum Neurosci 7, 00609. doi: 10.3389/fnhum.2013.00609.